Top

Published in:

01-06-2005 | Review

Assessment of fracture risk

Authors: John A. Kanis, Frederik Borgstrom, Chris De Laet, Helena Johansson, Olof Johnell, Bengt Jonsson, Anders Oden, Niklas Zethraeus, Bruce Pfleger, Nikolai Khaltaev

Published in: Osteoporosis International | Issue 6/2005

Abstract

The diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD). There are a number of clinical risk factors that provide information on fracture risk over and above that given by BMD. The assessment of fracture risk thus needs to be distinguished from diagnosis to take account of the independent value of the clinical risk factors. These include age, a prior fragility fracture, a parental history of hip fracture, smoking, use of systemic corticosteroids, excess alcohol intake and rheumatoid arthritis. The independent contribution of these risk factors can be integrated by the calculation of fracture probability with or without the use of BMD. Treatment can then be offered to those identified to have a fracture probability greater than an intervention threshold.

Anonymous (1993) Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650CrossRefPubMed

Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406PubMed

Royal College of Physicians (1999) Clinical guidelines for the prevention and treatment of osteoporosis. RCP, London

National Osteoporosis Foundation (1998) Analyses of the effectiveness and cost of screening and treatment strategies for osteoporosis: a basis for development of practice guidelines. Osteoporos Int 8 (suppl 4):1–88CrossRef

Kanis JA, Glüer CC for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202CrossRefPubMed

Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C et al. (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13:527–536CrossRefPubMed

World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. WHO, Geneva

Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:17–1141PubMed

Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteoporosis and osteopenia. Bone 27:585–590CrossRefPubMed

10.

Committee for Proprietary Medicinal Products (CPMP) (1997) Note for guidance on involutional osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95)

11.

World Health Organisation (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneva

12.

Liu, Z, Piao J, Pang L, Qing X et al. (2002) The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China. J Bone Miner Metab 20:181–189CrossRefPubMed

13.

Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int 69:218–221PubMed

14.

DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593PubMed

15.

Ross P, Huang C, Davis J, Imose K, Yates J, Vogel J, Wasnich R (1995) Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneous ultrasound. Bone 16:325–332CrossRefPubMed

16.

Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J (1997) Bone density variation and its effect on risk of vertebral deformity in men and women studied in thirteen European Centres: the EVOS Study. J Bone Miner Res 12:1883–1894PubMed

17.

Faulkner KG, von Stetten E, Miller P (1999) Discordance in patient classification using T-scores. J Clin Densitom 2:343–350CrossRefPubMed

18.

Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD (1997) Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 12:683–690

19.

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMed

20.

Cooper C, Aihie A (1994) Osteoporosis: recent advances in pathogenesis and treatment. Q J Med 87:203–209PubMed

21.

Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2001) Ten year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258CrossRef

22.

Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W (2000) Risk of hip fracture in Sweden according to relative risk: an analysis applied to the population of Sweden. Osteoporos Int 11:120–127PubMed

23.

Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 26:387–391CrossRefPubMed

24.

Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA (1999) Lifetime risk of hip fracture is underestimated. Osteoporos Int 8:599–603CrossRef

25.

Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809PubMed

26.

Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995CrossRefPubMed

27.

Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936CrossRefPubMed

28.

Johnell O, Gullberg B, Kanis JA et al. (1995) Risk factors for hip fracture in European women: the MEDOS Study. J Bone Miner Res 10:1802–1815PubMed

29.

Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767–773CrossRefPubMed

30.

Compston JE (1992) Risk factors for osteoporosis. Clin Endocrinol 36:223–224

31.

Ribot C, Pouilles JM, Bonneu M, Tremollieres F (1992) Assessment of the risk of postmenopausal osteoporosis using clinical risk factors. Clin Endocrinol 36:225–228

32.

Kanis JA, Johnell O, Gullberg B, Allander A, Elffors L, Dequeker J et al. (1999) Risk factors for hip fracture in European men. The MEDOS study. Osteoporos Int 9:45–54CrossRefPubMed

33.

Nguyen T, Sambrook SP, Kelly P, Jones G, Freund J, Eisman J (1993) Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307:1111–1115PubMed

34.

Poor G, Atkinson EJ, O’Fallon WM, Melton LJ III (1995) Predictors of hip fractures in elderly men. J Bone Miner Res 10:1900–1907PubMed

35.

Kanis JA, McCloskey EV (1996) Evaluation of the risk of hip fracture. Bone 18:127–132CrossRef

36.

Kanis JA, De Laet C, Delmas P, Garnero P, Johansson H, Johnell O, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Oden A, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and fracture risk. Bone 35:375–382CrossRef

37.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMed

38.

Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman AJ, Tenenhouse A (2004) Smoking and fracture risk: a meta-analysis. Osteoporos Int (in press)

39.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ, Pols HAP, Reeve J, Silman AJ, Tenenhouse A (2004) A family history of fracture and fracture risk: a meta-analysis. Bone (in press)

40.

De Laet C, Kanis JA, Oden A, Johansson H, Johnell O, Delmas P et al. (2004) Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int (in press)

41.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2004) Alcohol intake as a risk factor for fracture. Osteoporos Int (in press)

42.

Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2001) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

43.

Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787PubMed

44.

Klotzbuecher CM, Ross PD, Landsman PB, Abbot TA, Berger M (2000) Patients with prior fractures have increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–727PubMed

45.

Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non black, osteoporotic women. Osteoporos Int 3:120–126PubMed

46.

Delmas PD (ed) (2000) The use of biochemical markers of bone turnover in the management of post-menopausal osteoporosis. Osteoporosis Int 11:S1–S76CrossRef

47.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women. The Ofely study. J Bone Miner Res 15:1526–1536PubMed

48.

Garnero P, Hauser E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breard G, Meunier PJ, Delmas PD (1996) Markers of bone turnover predict hip fractures in elderly women. The EPIDOS prospective study. J Bone Miner Res 11:1531–1538PubMed

49.

Hansen M, Overgaard K, Riis B, Christiansen C (1991) Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303:961–964PubMed

50.

Johnell O, Oden A, DeLaet C, Garnero P, Delmas PD, Kanis JA (2002) Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523–526CrossRefPubMed

51.

Dyslipidaemia Advisory Group on behalf of the Scientific Committee of the National Heart Foundation of New Zealand (1996) National Heart Foundation Clinical Guidelines for the assessment and management of dyslipidaemia. N Z Med J 109:224–232PubMed

52.

Kanis JA, Dawson A, Oden A, Johnell O, De Laet C, Jonsson B (2001) Cost-effectiveness of preventing hip fracture in the general female population. Osteoporos Int 12:356–361CrossRefPubMed

53.

Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20–26CrossRefPubMed

54.

Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427CrossRefPubMed

55.

Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jonsson B (2002) Intervention thresholds for osteoporosis. Bone 13:26–31

56.

Kanis JA, Barton IP, Johnell O (2004) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (in press)

57.

Johansson H, Oden A, Johnell O, Jonsson B, De Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T, Kanis JA (2004) Optimisation of BMD measurements to identify high risk groups for treatment—a test analysis. J Bone Miner Res 19:906–913PubMed

Title: Assessment of fracture risk
Authors: John A. Kanis
Frederik Borgstrom
Chris De Laet
Helena Johansson
Olof Johnell
Bengt Jonsson
Anders Oden
Niklas Zethraeus
Bruce Pfleger
Nikolai Khaltaev
Publication date: 01-06-2005
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 6/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-004-1780-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Assessment of fracture risk

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2005

Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong)

Bone density and hemoglobin levels in older persons: results from the InCHIANTI study

Hand workload and the metacarpal cortical index. A study of middle-aged teachers and dentists

Determinants of changes in bone mass and femoral neck structure, and physical performance after menopause: a 9-year follow-up of initially peri-menopausal women

Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naïve postmenopausal women

Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population